Shanghai Institute Of Biological Products

This study tests a new flu vaccine in 120 adults aged 60 and older. Participants are randomly assigned to receive either the new vaccine, a standard flu vaccine, or a placebo. The goal is to check the vaccine's safety and how well it triggers an immune response.

This early-stage study is testing a new monkeypox vaccine in 120 healthy adults aged 18 and older. Participants will receive two doses of either the vaccine or a placebo, and researchers will closely monitor for side effects and measure the body's immune response. The goal is to …

This early-stage study is testing a new vaccine called SIBP-A16 to see if it is safe and how the body processes it. The trial involves 140 healthy adults aged 18 to 45. Researchers will monitor for side effects and measure how the vaccine behaves in the body. This is a first step…

This study tests a new shingles vaccine in 645 healthy adults aged 40 and older. Researchers will give two doses and check for side effects and immune response. The goal is to see if the vaccine is safe and helps the body fight the virus that causes shingles.

This early-phase study tests a new drug called SIBP-A13 in 144 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Researchers will also watch for a…

This early-stage trial is testing a new drug called SIBP-A18 in 156 adults aged 18-75 with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Researchers will …

This early-stage trial tests a new drug called SIBP-A19 in 156 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Participants will receive the dru…

This early-stage study tests a new injectable drug called peguricase, given together with methotrexate, in 36 adults with gout that standard treatments fail to control. The main goals are to check safety, how the drug moves through the body, and to find the right dose for future …

This study tests a new drug called SIBP-03 combined with cetuximab in people with advanced head and neck cancer that has come back or spread. It is for patients who have already tried immunotherapy and chemotherapy without success. The goal is to see if the combination can shrink…

This early-stage study tests a new drug called SIBP-A17 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 196 adults aged 18 to 75 will t…

This early-stage trial tests a new drug called SIBP-A10 in 160 adults with advanced tumors that have not responded to other treatments. The main goal is to check the drug's safety and find the best dose for future studies. Participants will be closely monitored for side effects a…